[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351656-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351656-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","surface-engineering-of-nk-cells-with-poly-l-glutamic-acid-enhances-tumor-selective-immunotherapy-against-ovarian-cancer","Surface Engineering of NK Cells with Poly-L-Glutamic Acid Enhances Tumor-Selective Immunotherapy Against Ovarian Cancer","","Natural killer (NK) cells offer strong potential for cancer immunotherapy because they can recognize and eliminate tumor cells without prior antigen sensitization, yet limited tumor recognition reduces their effectiveness against solid tumors. To overcome this, a lipid-mediated membrane engineering strategy was created to enhance NK targeting and cytotoxicity toward solid tumors, especially ovarian cancer. Poly-L-glutamic acid (PLE) was anchored to NK membranes using a lipid moiety, enabling rapid, non-genetic surface modification. Engineered PLE-NK cells displayed improved tumor-specific cytotoxicity, increased NK–cancer cluster formation, and disrupted 3D tumoroids, while showing no off-target effects on normal fibroblasts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/surface-engineering-of-nk-cells-with-poly-l-glutamic-acid-enhances-tumor-selective-immunotherapy-against-ovarian-cancer/351656/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/surface-engineering-of-nk-cells-with-poly-l-glutamic-acid-enhances-tumor-selective-immunotherapy-against-ovarian-cancer/351656.png","ImageObject",300,407,{"name":42,"@type":43},"Terk","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is tumor recognition a limitation for NK-cell immunotherapy against solid tumors?","Question",{"text":63,"@type":64},"Insufficient tumor recognition restricts the anticancer efficacy of NK cells against solid tumors, including ovarian cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does poly-L-glutamic acid (PLE) improve NK targeting?",{"text":68,"@type":64},"PLE is used as a tumor-targeting module because it has specific affinity for cholesterol-rich membrane domains, enabling direct recognition.",{"name":70,"@type":61,"acceptedAnswer":71},"Do PLE-lipid engineered NK cells harm normal cells?",{"text":72,"@type":64},"No off-target effects were observed on normal fibroblasts in the reported findings.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351656,1790192828,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nSurface Engineering of NK Cells with Poly-L-Glutamic Acid Enhances Tumor-Selective Immunotherapy Against Ovarian Cancer  \nYoonbum Park 1, Ashok Kumar Jangid 1, Kyung Mu Noh 1, Eunha Kim 1, Chae Eun Lee 1 and Kyobum Kim 1,2, *  \nAcademic Editor: Alessandro Poggi  \nReceived: 23 March 2026  \nRevised: 18 April 2026  \nAccepted: 25 April 2026  \nPublished: 28 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Chemical & Biochemical Engineering, Dongguk University, Seoul 04620, Republic of Korea; [dean4528@dgu.ac.kr](dean4528@dgu.ac.kr) (Y.P.); [ashok4483@gmail.com](ashok4483@gmail.com) (A.K.J.); [kyungmu.noh@dgu.ac.kr](kyungmu.noh@dgu.ac.kr) (K.M.N.); [kim4710@dgu.ac.kr](kim4710@dgu.ac.kr) (E.K.); [jum0051@dgu.ac.kr](jum0051@dgu.ac.kr) (C.E.L.)  \n2 Cellbastian Inc., 30, Pildong-ro 1-gil, Jung-gu, Seoul 04620, Republic of Korea  \n* Correspondence: [kyobum.kim@dongguk.edu](kyobum.kim@dongguk.edu)  \nHighlights  \nWhat are the main findings?  \n• Lipid-mediated surface engineering of NK cells with poly-L-glutamic acid (PLE) significantly enhanced effector–target interactions with ovarian cancer cells via cholesterolassociated membrane binding.  \n• PLE-coated NK cells exhibited markedly improved tumor-specific cytotoxicity without increasing off-target killing against normal fibroblasts.  \nWhat are the implications of the main findings?  \n• This receptor-independent membrane targeting strategy provides a versatile approach to enhance NK cell recognition of solid tumors.  \n• PLE-based surface engineering offers a simple and scalable platform to improve the efficacy and selectivity of NK cell-based cancer immunotherapy.  \nAbstract  \nNatural killer (NK) cells are promising effectors for cancer immunotherapy, as they can recognize and eliminate tumor cells without prior antigen sensitization. However, insufficient tumor recognition remains a critical limitation that reduces the anticancer efficacy of NK cells against solid tumors. To address this limitation, we developed a lipid-mediated cell membrane engineering strategy to enhance the targeting and cytotoxic efficacy of NK cells toward solid tumors, particularly ovarian cancer cells. In this strategy, poly-L-glutamic acid (PLE) was employed as an ovarian cancer-targeting module due to the specific affinity of PLE for cholesterol-rich membrane domains. To display PLE on NK cells, a lipid moiety is incorporated to anchor PLE onto the NK cell membrane via hydrophobic insertion, enabling rapid and non-genetic surface modification. As a result, the surface-engineered NK cells with PLE-Lipid (i.e., PLE-NK) displayed PLE on the NK cell surface, allowing direct recognition of ovarian cancer cells without compromising the intrinsic properties of NK cells. This enhanced recognition subsequently increased NK–cancer cluster formation by promoting interactions between membrane-presented PLE on NK cells and cholesterol on ovarian cancer cells. Consequently, PLE-NK cells exhibited enhanced cytotoxicity against ovarian cancer cells (i.e., OVCAR-3 cells) and effectively disrupted 3D tumoroids, while PLE-NK cells showed no off-target effects on normal fibroblasts. Collectively, these findings demonstrate that PLE-Lipid-mediated NK surface engineering provides a simple and effective strategy to improve the tumor targeting ability of NK cells and offers a promising platform for NK cell-based immunotherapy against ovarian cancer.  \nKeywords: natural killer cells; membrane engineering; ovarian cancer; poly-L-glutamic acid; tumor targeting; immunotherapy  \n1. Introduction  \nOvarian cancer is the fifth leading cause of cancer-related mortality among women worldwide while remaining one of the most difficult gynecologic malignancies to treat. Despite advances in cytoreductive surgery and systemic chemotherapy, overall survival ","cbCaiazo4tOEqdl1","https://ap.wps.com/l/cbCaiazo4tOEqdl1","pdf",3990450,21,"English","# Abstract\n# Keywords\n# 1. Introduction","[{\"question\":\"Why is tumor recognition a limitation for NK-cell immunotherapy against solid tumors?\",\"answer\":\"Insufficient tumor recognition restricts the anticancer efficacy of NK cells against solid tumors, including ovarian cancer.\"},{\"question\":\"How does poly-L-glutamic acid (PLE) improve NK targeting?\",\"answer\":\"PLE is used as a tumor-targeting module because it has specific affinity for cholesterol-rich membrane domains, enabling direct recognition.\"},{\"question\":\"Do PLE-lipid engineered NK cells harm normal cells?\",\"answer\":\"No off-target effects were observed on normal fibroblasts in the reported findings.\"}]","Surface Engineering of NK Cells with Poly-L-Glutamic Acid Enhances Tumor-Selective Immunotherapy Against Ovarian Cancer | PDF",1790095148,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/904edcdbf664f40ef27de2d600c7c142.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3010e626c54bc0f45dcf1fe2e4df1e8.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88bf59b3a565b550cc7a9c2bb6c8b31c.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a6df600666e5804f7b5f22baed4ac49c.webp",980,1385]